Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1765–1800
Headlines
3151
Sources here
15
Companies here
15
Current section United States Diagnostics & Research news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Illumina, Inc. Revenue Breakdown – LSX:927079

This article provides a revenue breakdown for Illumina, Inc. (LSX:927079), detailing its performance in the last fiscal year. The company generated 3.70 billion EUR, with its Core Illumina - Consumables segment being the top contributor at 2.75 billion EUR. Geographically, the United States was …

ILMN main company
Sharemaestro market context Trend signal active 52 weeks +87.5% ILMN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview

Fulgent Genetics Inc (FLGT) is projected to report a loss of 46 cents per share in its upcoming earnings announcement. This preview indicates the anticipated financial performance for the company, suggesting a negative earnings per share.

FLGT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.7% · Next-week setup negative 42.1% FLGT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Veracyte to present at two major healthcare investor conferences in August and September 2026

Veracyte, a cancer diagnostics company, announced its participation in two key healthcare investor conferences: the Canaccord Genuity Growth Conference in August and the Morgan Stanley Global Healthcare Conference in September 2026. The company will conduct fireside chats at both events to discuss its diagnostic …

VCYT main company
Sharemaestro market context Trend signal active 52 weeks +33.1% VCYT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IQVIA Holdings, Inc. Stock 12‑Month Price Target Raised to $232.22, Implies 9% Upside

Analysts have raised the average 12-month price target for IQVIA Holdings, Inc. (IQV) stock to $232.22, up from $230. This new target suggests a potential upside of approximately 9% based on the recent closing price. The consensus rating for IQV remains a "Buy" among …

IQV main company
Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6% IQV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FMS|Fresenius Medical Care AG|Price:24.880|Chg%:+0.130

This article provides a comprehensive stock analysis of Fresenius Medical Care AG (FMS), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation. It notes high institutional ownership and a medium-term upward trend prediction for the stock price, despite technicals not fully supporting …

DGX mentioned LH mentioned
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BlackRock (GRAL holder) discloses 7.9% GRAIL, Inc. stake in 13G/A

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.9% passive ownership stake in GRAIL, Inc. (GRAL). This ownership amounts to 3,376,085 shares of GRAIL common stock, with BlackRock holding sole voting power over 3,312,474 shares and sole dispositive power over all 3,376,085 …

GRAL main company
Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9% GRAL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NeoGenomics (NASDAQ:NEO) Posts Earnings Results, Beats Expectations By $0.02 EPS

NeoGenomics (NASDAQ:NEO) reported quarterly earnings that surpassed analyst expectations, with an EPS of $0.05 against an estimated $0.03, and revenue of $201.66 million, exceeding the $196.93 million estimate. Despite the positive earnings surprise, the company posted a negative net margin and return on equity. …

NEO main company
Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8% NEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: NeoGenomics tops Q2 2026 estimates and lifts outlook

NeoGenomics Inc. reported strong second-quarter 2026 earnings, surpassing Wall Street expectations for both profit and sales, driven by robust clinical and next-generation sequencing (NGS) business growth. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, despite continued weakness in its non-clinical pharma …

NEO main company
Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8% NEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fulgent Genetics CSO Gao Hanlin Executes Tax-Related Sale of 1,645 Shares at $19.67 on July 26, 2026

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, Inc. (NASDAQ: FLGT), sold 1,645 common shares at $19.67 each on July 26, 2026, to cover tax obligations. Following this transaction, Hanlin still directly owns 988,729 common shares in the genomics testing company. The sale was …

FLGT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.7% · Next-week setup negative 42.1% FLGT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BlackRock (NYSE: BLK) discloses 5.5% beneficial ownership in GeneDx (WGS)

BlackRock, Inc. has filed a Schedule 13G disclosing a 5.5% beneficial ownership in GeneDx Holdings Corp. (WGS). The filing indicates BlackRock owns 1,622,518 shares of Class A stock, with sole voting power over 1,588,670 shares and sole dispositive power over all 1,622,518 shares. No …

WGS main company
Sharemaestro market context Price above Trend Line 52 weeks -39.3% WGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NeoGenomics Releases Q2 2026 Financial Results

NeoGenomics, Inc. reported strong Q2 2026 financial results, with adjusted EPS of $0.05, significantly beating analyst estimates, and revenue of $201.7M, surpassing consensus. The company saw an 11.2% increase in revenue year-over-year, primarily driven by its clinical services segment. Management provided full-year adjusted EPS …

NEO main company
Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8% NEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IQVIA HOLDINGS INC. 2Q 2026: Revenue $4.37B, EPS $1.53— 10-Q Summary

IQVIA Holdings Inc. (IQV) reported its second-quarter 2026 results, showing an 8.7% year-over-year revenue increase to $4.37 billion. However, diluted EPS slightly declined to $1.53, and net income fell to $258 million. The company has reorganized into Commercial Solutions and R&D Solutions segments and …

IQV main company
Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6% IQV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Natera (NTRA) insider Michael Brophy files to sell 1,178 shares, lists prior sales

Natera executive Michael Brophy has filed a notice to sell 1,178 shares of common stock, stemming from Restricted Stock Units dated July 26, 2026. This SEC Form 144 filing also details several previous sales of Natera stock by Brophy over the past three months, …

NTRA main company
Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5% NTRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jonathan Sheena of NTRA plans 188-share stock sale (NASDAQ: NTRA)

Jonathan Sheena, an insider at Natera, Inc. (NASDAQ: NTRA), has filed a notice to sell 188 shares of common stock on July 28, 2026, with an estimated aggregate value of $48,509.64. This planned sale is related to 6,208 Restricted Stock Units granted in January …

NTRA main company
Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5% NTRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CRVO|CervoMed Inc|Price:2.555|Chg%:-0.005

This article provides a comprehensive stock analysis of CervoMed Inc (CRVO) by TradingKey. It highlights that CervoMed's fundamentals are healthy with significant growth potential, although its valuation is considered fairly valued within the Biotechnology & Medical Research industry. Analysts overwhelmingly rate it as a …

IQV mentioned
Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6% IQV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher (NYSE: TMO) COO sells 400 shares under 10b5-1 plan

Thermo Fisher Scientific Inc.'s President & COO, Gianluca Pettiti, sold 400 shares of common stock for $565.00 per share on July 27, 2026. This transaction, totaling $226,000, was conducted under a Rule 10b5-1 trading plan adopted in September 2025. Following the sale, Pettiti directly …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher Scientific Inc Stock (TMO) Closed Up by 3.20% on Jul 28: Drivers Behind the Movement

Thermo Fisher Scientific (TMO) stock increased by 3.20% due to strong quarterly earnings that surpassed estimates and an increased full-year organic revenue growth forecast. The company benefits from rising biopharma spending, demand for clinical services, and increased capital expenditure from pharmaceutical clients. Technical indicators …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

U.S. Markets Finished Mixed Tuesday As IQVIA Holdings Led, Amkor Technology Lagged

U.S. stock indexes ended Tuesday mixed, with the Dow Jones Industrial Average rising by 1.03% and the S&P 500 Index increasing by 0.21%. Conversely, the NASDAQ Composite Index experienced a slight decline of 0.22%. IQVIA Holdings led the market, while Amkor Technology lagged.

IQV main company
Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6% IQV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OPKO Health (OPK) VP withholds 53,266 shares for taxes

OPKO Health's Executive VP-Administration, Steven D. Rubin, reported a tax-related share withholding on July 24, 2026. A total of 53,266 shares of common stock, valued at $1.22 per share, were withheld to cover tax obligations stemming from vested restricted stock units. Following this transaction, …

OPK main company
Sharemaestro market context Trend signal active 52 weeks -2.1% OPK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Veracyte to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will be participating in the following investor conferences: Canaccord Genuity 46th Annual Growth Conference – Boston, MA Fireside chat on Tuesday, …

VCYT main company
Sharemaestro market context Trend signal active 52 weeks +33.1% VCYT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

METTLER TOLEDO INTERNATIONAL INC/ SEC Filing (Jul 28, 2026)

This article reports on a Form 144 SEC filing by METTLER TOLEDO INTERNATIONAL INC. (MTD) on July 28, 2026. The filing indicates a proposed sale of 832 shares of common stock acquired through a stock option exercise on November 3, 2016, with an aggregate …

MTD main company
Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4% MTD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GRAL 1-WEEK DEADLINE ALERT: GRAIL, Inc. (NASDAQ: GRAL)

Hagens Berman Sobol Shapiro LLP has filed a securities fraud class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL), urging investors with substantial losses to join before the August 4, 2026, lead plaintiff deadline. The lawsuit alleges that GRAIL and its executives misled investors about …

GRAL main company
Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9% GRAL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

WGS 6-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

Hagens Berman Sobol Shapiro LLP has filed a securities fraud class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS), urging investors with substantial losses to contact the firm before the August 3, 2026, lead plaintiff deadline. The lawsuit alleges GeneDx misled investors about the …

WGS main company
Sharemaestro market context Price above Trend Line 52 weeks -39.3% WGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Michael Brophy plans Natera (NTRA) stock sale after recent trades

Insider Michael Brophy has filed a Form 144 notice indicating his intent to sell 1,222 shares of Natera (NTRA) common stock. These shares originate from Restricted Stock Units granted on January 27, 2023. The filing also details Brophy's previous sales of Natera stock over …

NTRA main company
Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5% NTRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Natera insider plans sale of 988 shares | NTRA SEC Filing - Form 144

Daniel Rabinowitz, an insider at Natera (NTRA), has filed a Form 144 to sell 988 shares of common stock, valued at $254,933.64, on or after July 28, 2026. The filing also details previous sales by Rabinowitz, including 33,600 shares for over $8.4 million on …

NTRA main company
Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5% NTRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Natera (NTRA) insider John Fesko plans $236K sale of common stock

John Fesko, an insider at Natera, Inc. (NTRA), plans to sell 917 shares of common stock on or about July 28, 2026, with an estimated aggregate value of $236,613.51. These shares originated from Restricted Stock Units granted on January 27, 2023. This planned sale …

NTRA main company
Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5% NTRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Steven Chapman (NASDAQ: NTRA) plans $909K sale of common shares

Steven Chapman, an affiliate of Natera, Inc. (NASDAQ: NTRA), has filed a Form 144 notice indicating a planned sale of 3,525 common shares with an aggregate market value of $909,555.75, set to occur on or after July 28, 2026, on NASDAQ. These shares are …

NTRA main company
Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5% NTRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BEAM|Beam Therapeutics Inc|Price:26.300|Chg%:+1.230

This article provides a comprehensive stock analysis of Beam Therapeutics Inc (BEAM) by TradingKey, detailing its financial health, valuation, growth potential, and institutional confidence. The company-s fundamentals are considered healthy with high growth potential, and its valuation is deemed fairly valued within the Biotechnology …

IQV mentioned
Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6% IQV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Veracyte to offer live audio webcasts for two investor chats

Veracyte (Nasdaq: VCYT) announced its participation in two upcoming investor conferences: the Canaccord Genuity 46th Annual Growth Conference on August 11, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15. The company will host live audio webcasts and 90-day replays of …

VCYT main company
Sharemaestro market context Trend signal active 52 weeks +33.1% VCYT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Exagen's Aug. 11 fireside chat will be live and archived

Exagen Inc. (Nasdaq: XGN) announced that its management will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on August 11, 2026. The company will host a Fireside Chat at 8:30 a.m. ET, with live and archived webcasts available on its …

XGN main company
Sharemaestro market context Trend signal active 52 weeks -34.1% XGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Exagen Inc. to Participate in Upcoming Investor Conference

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced its management will participate in the Canaccord Genuity 46th Annual Growth Conference. The company will host a Fireside Chat on August 11, 2026, at 8:30 am ET, which will be available via webcast …

XGN main company
Sharemaestro market context Trend signal active 52 weeks -34.1% XGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IQVIA Stock Pops As Analysts Hike Price Targets Again

IQVIA Holdings Inc. (IQV) stock surged by 12.12% recently, driven by news of a transformative clinical data-analytics partnership and multiple analyst price target hikes. Firms like HSBC and Deutsche Bank have raised their targets, citing anticipated healthcare outperformance and overstated fears regarding AI/ML disruption. …

IQV main company
Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6% IQV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cantor Fitzgerald reiterates Insmed stock rating on Brensupri sales outlook

Cantor Fitzgerald has reiterated an Overweight rating and a $235.00 price target for Insmed Inc. (NASDAQ:INSM), noting that the stock has remained flat as investors await upcoming catalysts. The firm estimates second-quarter Brensupri sales to be around $285 million, based on weekly script data, …

IQV mentioned
Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6% IQV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AIRS|Airsculpt Technologies Inc|Price:4.423|Chg%:-0.237

This article provides a comprehensive stock analysis of Airsculpt Technologies Inc (AIRS), highlighting its strong fundamentals, high growth potential, and "fairly valued" status within the Healthcare Providers & Services industry. It notes high institutional ownership and anticipates an upward trend in the medium term, …

DGX mentioned LH mentioned
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Portnoy Law Firm Announces Class Action on Behalf of GeneDX Holdings, Corp. Investors

The Portnoy Law Firm has announced a class action lawsuit on behalf of investors in GeneDX Holdings, Corp. (NASDAQ: WGS). The lawsuit alleges that GeneDX made false and misleading statements to investors between April 16, 2025, and May 4, 2026, regarding its business, including …

WGS main company
Sharemaestro market context Price above Trend Line 52 weeks -39.3% WGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Twist Bioscience Market Sentiment

This article provides an overview of market sentiment for Twist Bioscience (TWST), detailing analyst consensus, short interest, options flow, and insider activity. It highlights a "Buy" analyst consensus, a 25.7% declining short float, and a bullish options flow with a 0.52 Put/Call ratio, despite …

TWST main company
Sharemaestro market context Trend signal active 52 weeks +314.7% TWST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context